Xiuhui Chen, Rui Long, Fengdan Xu, Weijun Ye, Ning Li
{"title":"NLRP3炎性体在坏死性小肠结肠炎中的作用。","authors":"Xiuhui Chen, Rui Long, Fengdan Xu, Weijun Ye, Ning Li","doi":"10.1038/s41390-025-04081-2","DOIUrl":null,"url":null,"abstract":"<p><p>This review explores the association between the NOD-like receptor pyrin domain-containing protein 3 (NLRP3) inflammasomes and necrotizing enterocolitis (NEC) in neonates. It underscores the role of NLRP3 inflammasome overactivation in NEC pathogenesis and proposes that inhibiting NLRP3 inflammasome activation may improve therapeutic benefits. This review examines various strategies to inhibit NLRP3 inflammasome activation, detailing their pharmacological mechanisms. IMPACT: The aim of this review is to discuss the role of NLRP3 inflammasome in the progression of NEC. Abnormal NLRP3 inflammasome activation in patients with NEC and experimental models. Molecules and proteins have been identified as regulators of NLRP3 inflammasome activity, offering avenues for NEC treatment. The NLRP3 inflammasome is a key contributor to NEC. Novel NLRP3 inflammasome inhibitors are the focus of the development of NEC therapeutics.</p>","PeriodicalId":19829,"journal":{"name":"Pediatric Research","volume":" ","pages":""},"PeriodicalIF":3.1000,"publicationDate":"2025-06-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The role of NLRP3 inflammasome in necrotizing enterocolitis.\",\"authors\":\"Xiuhui Chen, Rui Long, Fengdan Xu, Weijun Ye, Ning Li\",\"doi\":\"10.1038/s41390-025-04081-2\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>This review explores the association between the NOD-like receptor pyrin domain-containing protein 3 (NLRP3) inflammasomes and necrotizing enterocolitis (NEC) in neonates. It underscores the role of NLRP3 inflammasome overactivation in NEC pathogenesis and proposes that inhibiting NLRP3 inflammasome activation may improve therapeutic benefits. This review examines various strategies to inhibit NLRP3 inflammasome activation, detailing their pharmacological mechanisms. IMPACT: The aim of this review is to discuss the role of NLRP3 inflammasome in the progression of NEC. Abnormal NLRP3 inflammasome activation in patients with NEC and experimental models. Molecules and proteins have been identified as regulators of NLRP3 inflammasome activity, offering avenues for NEC treatment. The NLRP3 inflammasome is a key contributor to NEC. Novel NLRP3 inflammasome inhibitors are the focus of the development of NEC therapeutics.</p>\",\"PeriodicalId\":19829,\"journal\":{\"name\":\"Pediatric Research\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":3.1000,\"publicationDate\":\"2025-06-05\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Pediatric Research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1038/s41390-025-04081-2\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PEDIATRICS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pediatric Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1038/s41390-025-04081-2","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PEDIATRICS","Score":null,"Total":0}
The role of NLRP3 inflammasome in necrotizing enterocolitis.
This review explores the association between the NOD-like receptor pyrin domain-containing protein 3 (NLRP3) inflammasomes and necrotizing enterocolitis (NEC) in neonates. It underscores the role of NLRP3 inflammasome overactivation in NEC pathogenesis and proposes that inhibiting NLRP3 inflammasome activation may improve therapeutic benefits. This review examines various strategies to inhibit NLRP3 inflammasome activation, detailing their pharmacological mechanisms. IMPACT: The aim of this review is to discuss the role of NLRP3 inflammasome in the progression of NEC. Abnormal NLRP3 inflammasome activation in patients with NEC and experimental models. Molecules and proteins have been identified as regulators of NLRP3 inflammasome activity, offering avenues for NEC treatment. The NLRP3 inflammasome is a key contributor to NEC. Novel NLRP3 inflammasome inhibitors are the focus of the development of NEC therapeutics.
期刊介绍：
Pediatric Research publishes original papers, invited reviews, and commentaries on the etiologies of children''s diseases and
disorders of development, extending from molecular biology to epidemiology. Use of model organisms and in vitro techniques
relevant to developmental biology and medicine are acceptable, as are translational human studies
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
